Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model

Current Alzheimer Research

Volumn 7, Issue 3, 2010, Pages 255-261

  Chen, B ^a   Bromley Brits, K ^a,b   He, G ^a   Cai, F ^a   Zhang, X ^c   Song, W ^a,b  

^a Brain Research Center   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

A; Alzheimer; Cannabinoids; Hu210; Memory deficits; Neurogenesis

Indexed keywords

AMYLOID; CANNABINOID; DEXANABINOL;

ALZHEIMER DISEASE; AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFECT; FEMALE; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; COGNITION DISORDERS; CONDITIONING (PSYCHOLOGY); DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; FEMALE; HUMANS; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; NEUROPROTECTIVE AGENTS; SENILE PLAQUES; TETRAHYDROCANNABINOL; TREATMENT FAILURE;

EID: 77952476532     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720510791050948     Document Type: Article

References (37)

1. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61: 352-355 (1993).
2. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949 (1992).
3. Bisogno T, Sepe N, Melck D, Maurelli S, Petrocellis LD, Marzo VD. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2- arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 322(Pt 2): 671-677 (1997).
4. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. Identification of an endogenous 2- monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90 (1995).
5. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778 (1997).
6. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884 (2003).
7. Aguado T, Monory K, Palazuelos J, et al. Beta-amyloid stimulation of inducible nitric- oxide synthase in astrocytes is interleukin1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275: 7918-7924 (2000).
8. Benito C, Bilkei-Gorzo A, Racz I, Valverde O, Otto M, Michel K, et al. Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci USA 102: 15670-15675 (2005).
9. Jin K, Xie L, Kim SH, Parmentier-Batteur S, Sun Y, Mao XO, et al. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol Pharmacol 66: 204-208 (2004).
10. Kim SR, Lee DY, Chung ES, Oh UT, Kim SU, Jin BK. Transient receptor potential vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro. J Neurosci 25: 662-671 (2005).
11. Jiang W, Zhang Y, Xiao L, Cleemput JV, Ji S-P, Bai G, et al. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. J Clin Invest 115: 3104-3116 (2005).
12. Skaper SD, Buriani A, Toso RD, Petrelli L, Romanello S, Facci L, et al. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci USA 93: 3984-3989 (1996).
13. Harris RA, Stokes JA. Cannabinoids inhibit calcium uptake by brain synaptosomes. J Neurosci 2: 443-447 (1982).
14. Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt P, Wolf S, et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49: 67-79 (2006).
15. Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22: 257-264 (2006).
16. van der Stelt M, Marzo VD. Cannabinoid receptors and their role in neuroprotection. Neuromol Med 7: 37-50 (2005).
17. Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278: 157-160 (2000).
18. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531 (2001).
19. van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 21: 8765-8771 (2001).
20. Abood ME, Rizvi G, Sallapudi N, McAllister SD. Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity. Neurosci Lett 309: 197-201 (2001).
21. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19: 2987-2995 (1999).
22. Bonfils PK, Reith J, Hasseldam H, Johansen FF. Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia. Neurochem Int 49: 508-518 (2006).
23. Leker RR, Gai N, Mechoulam R, Ovadia H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 34: 2000-2006 (2003).
24. Molina-Holgado E, Vela JM, Arevalo-Martin A, Almazan G, Molina-Holgado F, Borrell J, et al. Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci 22: 9742-9753 (2002).
25. Yang C, Hader W, Zhang X. Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite. Brain Res 1076: 238-242 (2006).
26. Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernandez-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiol Dis 19: 96-107 (2005).
27. van der Stelt M, Mazzola C, Esposito G, Matias I, Petrosino S, De Filippis D, et al. Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels. Cell Mol Life Sci 63: 1410-1424 (2006).
28. Milton NG. Anandamide and noladin ether prevent neurotoxicity of the human amyloid- beta peptide. Neurosci Lett 332: 127-130 (2002).
29. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA- DR. Neurosci Lett 79: 195-200 (1987).
30. McGeer PL, Itagaki S, Tago H, McGeer EG. Occurrence of HLA-DR reactive microglia in Alzheimer's disease. Ann NY Acad Sci 540: 319-323 (1988).
31. Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 25: 1904-1913 (2005).
32. Matsuoka Y, Picciano M, Malester B, et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am J Pathol 158: 1345-1354 (2001).
33. Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mish C, Rothacher S, et al. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94: 13287-13292 (1997).
34. Qing H, Zhou W, Christensen MA, Sun X, Tong Y, Song W. Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J 18: 1571-1573 (2004).
35. Sun X, He G, Song W. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20: 1369-1376 (2006b).
36. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci USA 103: 18727-18732 (2006a).
37. Kochman LJ, Santos AAD, Fornal CA, Jacobs BL. Despite strong behavioral disruption, Delta(9)-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Res 1113: 86-93 (2006).